SSR3: A Potential Drug Target and Biomarker (G6747)
SSR3: A Potential Drug Target and Biomarker
SSR3 (Translocon-associated protein subunit gamma) is a protein that is expressed in various tissues and cells throughout the body. It is a key component of the translocation complex, which is responsible for the transfer of chromosomes during cell division. Studies have suggested that SSR3 may have various functions, including regulating cell division, DNA replication, and repair, and influencing cellular processes such as cell adhesion and migration.
One of the most promising aspects of SSR3 is its potential as a drug target. Several studies have shown that inhibiting SSR3 can lead to therapeutic effects in various models of disease, including cancer, neurodegenerative diseases, and developmental disorders. Additionally, SSR3 has been implicated in the development of certain diseases, such as neurofibromatosis, a genetic disorder that causes tumors and other neurological problems.
SSR3 is also a potential biomarker for several diseases. Its expression has been detected in a variety of disease tissues, including cancer, neurodegenerative diseases, and neurological disorders. Additionally, studies have shown that SSR3 levels can be affected by various factors, such as nutrient availability, exercise, and stress, which could make it a useful indicator of disease status or response to treatment.
In addition to its potential therapeutic and biomarker applications, SSR3 is also of interest to researchers because of its unique structure and biology. SSR3 is a member of the transmembrane protein family, which includes a variety of proteins that span the cell membrane and play important roles in cellular signaling and transport. Unlike many other proteins, SSR3 is not a typical cytoplasmic protein, meaning it does not float in the cytoplasm but is instead associated with the endoplasmic reticulum, a system of membrane-bound proteins that transports proteins between the cytoplasm and the endoplasmic reticulum.
The unique structure and biology of SSR3 have led to a growing interest in its potential functions and applications. One possibility is that SSR3's unusual structure may confer certain benefits in the cell, such as increased stability or resilience to environmental changes. Additionally, its association with the endoplasmic reticulum suggests that it may play a role in the regulation of protein synthesis and degradation, which is important for maintaining cellular homeostasis.
In conclusion, SSR3 is a protein that has broad potential as a drug target and biomarker. Its unique structure and biology, as well as its association with the endoplasmic reticulum, suggest that it may play important roles in cellular signaling and transport. Further research is needed to fully understand its functions and potential applications in disease.
Protein Name: Signal Sequence Receptor Subunit 3
Functions: TRAP proteins are part of a complex whose function is to bind calcium to the ER membrane and thereby regulate the retention of ER resident proteins
More Common Targets
SSR4 | SSR4P1 | SSRP1 | SST | SSTR1 | SSTR2 | SSTR3 | SSTR4 | SSTR5 | SSTR5-AS1 | SSU72 | SSU72L2 | SSU72P1 | SSU72P8 | SSUH2 | SSX1 | SSX2 | SSX2IP | SSX3 | SSX4 | SSX5 | SSX6P | SSX7 | SSX8P | SSX9P | SSXP10 | SSXP5 | ST13 | ST13P16 | ST13P18 | ST13P20 | ST13P4 | ST13P5 | ST14 | ST18 | ST20 | ST20-AS1 | ST20-MTHFS | ST3GAL1 | ST3GAL2 | ST3GAL3 | ST3GAL3-AS1 | ST3GAL4 | ST3GAL5 | ST3GAL5-AS1 | ST3GAL6 | ST3GAL6-AS1 | ST6GAL1 | ST6GAL2 | ST6GALNAC1 | ST6GALNAC2 | ST6GALNAC3 | ST6GALNAC4 | ST6GALNAC4P1 | ST6GALNAC5 | ST6GALNAC6 | ST7 | ST7-AS1 | ST7-OT3 | ST7-OT4 | ST7L | ST8SIA1 | ST8SIA2 | ST8SIA3 | ST8SIA4 | ST8SIA5 | ST8SIA6 | ST8SIA6-AS1 | STAB1 | STAB2 | STAC | STAC2 | STAC3 | STAG1 | STAG2 | STAG3 | STAG3L1 | STAG3L2 | STAG3L3 | STAG3L4 | STAG3L5P | STAG3L5P-PVRIG2P-PILRB | STAGA complex | Stage selector protein complex | STAM | STAM-DT | STAM2 | STAMBP | STAMBPL1 | STAP1 | STAP2 | STAR | STARD10 | STARD13 | STARD3 | STARD3NL | STARD4 | STARD4-AS1 | STARD5 | STARD6